PARIS – If no one else was in this space, investors might wonder what we are doing here. That is the rationale given by Gerard Brett, the CEO of Galway, Ireland-based Vivasure Medical Ltd. in response to the fierce competition emerging in the market for vascular closure devices (VCD) for the increasingly large incisions in femoral arteries made to accommodate advanced percutaneous interventions.